Nymox Pharmaceutical
NYMX
#10189
Rank
โ‚ฌ15.67 M
Marketcap
Country
0,17ย โ‚ฌ
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Nymox Pharmaceutical (NYMX) - Total liabilities

Total liabilities on the balance sheet as of June 2023 : โ‚ฌ2.7 Million

According to Nymox Pharmaceutical's latest financial reports the company's total liabilities are โ‚ฌ2.7 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Nymox Pharmaceutical - Total liabilities on balance sheet (from 2001 to 2023)

Total liabilities by year

Year Total liabilities Change
2022-12-31โ‚ฌ1.96 M14.14%
2021-12-31โ‚ฌ1.72 M-3.7%
2020-12-31โ‚ฌ1.78 M-1.92%
2019-12-31โ‚ฌ1.82 M94.07%
2018-12-31โ‚ฌ0.93 M-49.49%
2017-12-31โ‚ฌ1.85 M-27.56%
2016-12-31โ‚ฌ2.56 M-19.05%
2015-12-31โ‚ฌ3.16 M-31.21%
2014-12-31โ‚ฌ4.6 M-9.42%
2013-12-31โ‚ฌ5.08 M-26.86%
2012-12-31โ‚ฌ6.95 M-21.96%
2011-12-31โ‚ฌ8.91 M-27.53%
2010-12-31โ‚ฌ12.29 M592.93%
2009-12-31โ‚ฌ1.77 M97.39%
2008-12-31โ‚ฌ0.89 M1.39%
2007-12-31โ‚ฌ0.88 M-45.43%
2006-12-31โ‚ฌ1.62 M-23.21%
2005-12-31โ‚ฌ2.11 M39.79%
2004-12-31โ‚ฌ1.51 M10.55%
2003-12-31โ‚ฌ1.36 M-2.73%
2002-12-31โ‚ฌ1.4 M66.34%
2001-12-31โ‚ฌ0.84 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Abbott Laboratories
ABT
โ‚ฌ28.27 B 1,045,548.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ99.31 B 3,673,184.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚ฌ7.57 B 280,109.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ78.23 B 2,893,311.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ97.51 B 3,606,602.67%๐Ÿ‡บ๐Ÿ‡ธ USA